Cargando…

Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections

Due to the high risk of an outbreak of pandemic influenza, the development of a broadly protective universal influenza vaccine is highly warranted. The design of such a vaccine has attracted attention and much focus has been given to nanoparticle-based influenza vaccines which can be administered in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernasconi, Valentina, Bernocchi, Beatrice, Ye, Liang, Lê, Minh Quan, Omokanye, Ajibola, Carpentier, Rodolphe, Schön, Karin, Saelens, Xavier, Staeheli, Peter, Betbeder, Didier, Lycke, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146233/ https://www.ncbi.nlm.nih.gov/pubmed/30271406 http://dx.doi.org/10.3389/fimmu.2018.02060

Ejemplares similares

Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
por: Omokanye, Ajibola, et al.
Publicado: (2022)

Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles
por: Lê, Minh Quan, et al.
Publicado: (2018)

The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization
por: Schussek, Sophie, et al.
Publicado: (2020)

Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties
por: Betbeder, Didier, et al.
Publicado: (2015)

Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells
por: Salah, Norhane, et al.
Publicado: (2022)

Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles
por: Bernocchi, B., et al.
Publicado: (2016)

Vectorization by nanoparticles decreases the overall toxicity of airborne pollutants
por: Carpentier, Rodolphe, et al.
Publicado: (2017)

Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies
por: Sei, Clara J., et al.
Publicado: (2021)

ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection
por: Arabpour, Mohammad, et al.
Publicado: (2022)

Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep
por: Ducournau, Céline, et al.
Publicado: (2020)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019)

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
por: Wang, Jiong, et al.
Publicado: (2018)

Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
Publicado: (2021)

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis
por: Arabpour, Mohammad, et al.
Publicado: (2022)

Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus
por: Zhang, Yun, et al.
Publicado: (2019)

Molecular Docking of Broad-Spectrum Antibodies on Hemagglutinins of Influenza A Virus
por: Le, Khanh PB, et al.
Publicado: (2019)

Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity
por: Nedrud, John G., et al.
Publicado: (2013)

Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice
por: Sim, Sang-Hee, et al.
Publicado: (2016)

In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity
por: Wu, Nicholas C., et al.
Publicado: (2017)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
por: Goff, Peter H., et al.
Publicado: (2013)

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
por: Corder, Brigette N., et al.
Publicado: (2019)

Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
por: Zhu, Xueyong, et al.
Publicado: (2022)

Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines
por: Nagashima, Kaito, et al.
Publicado: (2023)

Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism
por: Ye, Liang, et al.
Publicado: (2021)

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
por: Kanekiyo, Masaru, et al.
Publicado: (2019)

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
por: Zhang, Limin, et al.
Publicado: (2022)

Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
por: Nguyen-Contant, Phuong, et al.
Publicado: (2021)

Hemagglutinin Stability Determines Influenza A Virus Susceptibility to a Broad-Spectrum Fusion Inhibitor Arbidol
por: Li, Zhenyu, et al.
Publicado: (2022)

Starch-based NP act as antigen delivery systems without immunomodulating effect
por: Fasquelle, François, et al.
Publicado: (2022)

One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I
por: Saelens, Xavier
Publicado: (2016)

Mucosal Vaccine Development Based on Liposome Technology
por: Bernasconi, Valentina, et al.
Publicado: (2016)

Insight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus Hemagglutinin
por: Cho, Ki Joon, et al.
Publicado: (2014)

Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
por: Wang, Taia T., et al.
Publicado: (2010)

How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin
por: Doud, Michael B., et al.
Publicado: (2018)

Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
por: Yassine, Hadi M., et al.
Publicado: (2018)

Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus
por: Bullard, Brianna L., et al.
Publicado: (2021)

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus
por: Huang, Jingjin, et al.
Publicado: (2020)

Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine
por: Dzimianski, John V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_57sgsntums7l7tt1f93gisnbr0